Ten of these 11 athletes were negative for AD pathology across all of their visits; with 1 retired athlete having plasma p-tau181 values consistent with the presence of AD pathology four years post-tau-PET visit, and therefore, this participant was excluded from this study. The gene discussed is MAPT; the disease is Alzheimer disease.